Why the study?
Do baseline plasma TIMP-4 levels predict all-cause mortality and myocardial infarction in male patients with diabetes mellitus referred for coronary angiography?
Do baseline plasma TIMP-4 levels predict all-cause mortality and myocardial infarction in male patients with diabetes mellitus referred for coronary angiography?
Elevated baseline plasma TIMP-4 levels independently predict 5-year all-cause mortality and myocardial infarction in male diabetic patients referred for coronary angiography.
Answers are grounded in this paper and cite their sources.
Identifies TIMP-4 as a potential prognostic biomarker in diabetic men undergoing angiography.
TIMP-4 is the newest member of a family of secreted proteins known as the tissue inhibitors of metalloproteases that selectively inhibit matrix metalloproteases. TIMP-4 is abundantly expressed in human cardiovascular structures and has been implicated in cardiovascular disease. Furthermore, it has also been shown to be a novel target of peroxisome proliferator-activated receptor gamma in rat smooth muscle cells, suggesting a potential role in diabetes mellitus as well. However, there have been no studies that have specifically examined the utility of baseline plasma TIMP-4 levels for the prediction of long-term adverse cardiovascular outcomes. In this study, baseline plasma TIMP-4 levels were measured in 162 male patients with diabetes mellitus who were referred for coronary angiography and followed prospectively for the development of all-cause mortality and enzymatically confirmed myocardial infarction (MI) out to 5 years. After adjustment for a variety of baseline clinical, angiographic and laboratory parameters, plasma TIMP-4 levels were an independent predictor of all-cause mortality (hazard ratio 1.60, 95% CI 1.13 to 2.26; p = 0.0082) and MI (hazard ratio 1.61, 95% CI 1.19 to 2.18; p = 0.0021) at 5 years. Furthermore, in additional multivariate models that adjusted for a variety of biomarkers with established prognostic efficacy, TIMP-4 remained an independent predictor of adverse outcomes. In conclusion, elevated levels of TIMP-4 are associated with an increased risk of long-term all-cause mortality and MI in patients with diabetes mellitus referred for coronary angiography. Moreover, this association is independent of a variety of clinical, angiographic, and laboratory variables, including biomarkers with established prognostic efficacy in the prediction of adverse cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Çavuşoğlu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: